Hydreight Technologies Inc. (TSXV:NURS)

Total Valuation

TSXV:NURS has a market cap or net worth of CAD 234.46 million. The enterprise value is 229.11 million.

Market Cap	234.46M
Enterprise Value	229.11M

Important Dates

The next estimated earnings date is Friday, November 21, 2025.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

TSXV:NURS has 47.27 million shares outstanding. The number of shares has increased by 9.85% in one year.

Current Share Class	47.27M
Shares Outstanding	47.27M
Shares Change (YoY)	+9.85%
Shares Change (QoQ)	+9.86%
Owned by Insiders (%)	3.28%
Owned by Institutions (%)	1.10%
Float	20.39M

Valuation Ratios

The trailing PE ratio is 166,402.20 and the forward PE ratio is 23.62.

PE Ratio	166,402.20
Forward PE	23.62
PS Ratio	12.68
PB Ratio	68.69
P/TBV Ratio	163.38
P/FCF Ratio	206.29
P/OCF Ratio	205.93
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	162,602.17
EV / Sales	12.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	201.58

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.22.

Current Ratio	1.49
Quick Ratio	1.41
Debt / Equity	0.22
Debt / EBITDA	4.21
Debt / FCF	0.66
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 0.18% and return on invested capital (ROIC) is -7.44%.

Return on Equity (ROE)	0.18%
Return on Assets (ROA)	-1.54%
Return on Invested Capital (ROIC)	-7.44%
Return on Capital Employed (ROCE)	-3.36%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	3.27
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +942.55% in the last 52 weeks. The beta is 0.60, so TSXV:NURS's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+942.55%
50-Day Moving Average	3.94
200-Day Moving Average	2.34
Relative Strength Index (RSI)	64.88
Average Volume (20 Days)	138,107

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:NURS had revenue of CAD 18.48 million and earned 1,409 in profits. Earnings per share was 0.00.

Revenue	18.48M
Gross Profit	6.34M
Operating Income	-139,904
Pretax Income	1,409
Net Income	1,409
EBITDA	178,176
EBIT	-139,904
Earnings Per Share (EPS)	0.00

Balance Sheet

The company has 6.10 million in cash and 749,879 in debt, giving a net cash position of 5.35 million or 0.11 per share.

Cash & Cash Equivalents	6.10M
Total Debt	749,879
Net Cash	5.35M
Net Cash Per Share	0.11
Equity (Book Value)	3.41M
Book Value Per Share	0.08
Working Capital	2.19M

Cash Flow

In the last 12 months, operating cash flow was 1.14 million and capital expenditures -1,995, giving a free cash flow of 1.14 million.

Operating Cash Flow	1.14M
Capital Expenditures	-1,995
Free Cash Flow	1.14M
FCF Per Share	0.02

Margins

Gross margin is 34.30%, with operating and profit margins of -0.76% and 0.01%.

Gross Margin	34.30%
Operating Margin	-0.76%
Pretax Margin	0.01%
Profit Margin	0.01%
EBITDA Margin	0.96%
EBIT Margin	-0.76%
FCF Margin	6.15%

Dividends & Yields

TSXV:NURS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.85%
Shareholder Yield	-9.85%
Earnings Yield	0.00%
FCF Yield	0.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 25, 2022. It was a reverse split with a ratio of 0.1546061.

Last Split Date	Nov 25, 2022
Split Type	Reverse
Split Ratio	0.1546061

Scores

TSXV:NURS has an Altman Z-Score of 6.37 and a Piotroski F-Score of 4.

Altman Z-Score	6.37
Piotroski F-Score	4